de Kouchkovsky I, Rao A, Carneiro BA, Zhang L, et al. A phase Ib/II study of the CDK 4/6 inhibitor ribociclib in combination with docetaxel plus prednisone in metastatic castration-resistant prostate cancer. Clin Cancer Res 2022 Feb 17. pii: 681559. doi: 10.1158/1078-0432.CCR-21-4302.
PMID: 35176163